OncoCyte Corp (STU:7OC0)
€ 3.34 0 (0%) Market Cap: 33.81 Mil Enterprise Value: 31.74 Mil PE Ratio: 0 PB Ratio: 1.89 GF Score: 32/100

Q3 2019 OncoCyte Corp Earnings Call Transcript

Nov 14, 2019 / 09:30PM GMT
Release Date Price: €28.4 (-4.05%)
Operator

Greetings and welcome to the OncoCyte Corporation Third Quarter 2019 Earnings Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Mr. Bob Yedid of LifeSci Advisors. Thank you, Mr. Yedid. You may begin.

Robert A. Yedid
LifeSci Advisors, LLC - MD

Thank you, Alexi, and thank you, everyone, for joining today's conference call to discuss OncoCyte's third quarter 2019 financial results and recent operating highlights. If you have not seen today's financial results press release, please visit OncoCyte's website at www.oncocyte.com.

Before turning the call over to Ronnie Andrews, OncoCyte's President and Chief Executive Officer, I would like to remind you that during this call, the company will make projections and forward-looking statements regarding future events. Any statements that are not historical fact, including, but not limited to, statements that contain words such as will, believes, plans,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot